Back to search

RNA Interference Targeting Aurora Kinase A Suppresses Tumor Growth and Enhances the Taxane Chemosensitivity in Human Pancreatic Cancer Cells

Data up to Jan 2025

Published2005
Citations217
References32

Total Citations Per Year

Abstract

References (32)

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

2001 • 9,275 citations

A System for Stable Expression of Short Interfering RNAs in Mammalian Cells

2002 • 4,334 citations

Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation

1998 • 1,288 citations

A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers

1998 • 1,210 citations

Stable suppression of tumorigenicity by virus-mediated RNA interference

2002 • 1,147 citations

Pancreatic cancer biology and genetics

2002 • 1,105 citations

VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo

2004 • 944 citations

ZD1839, a Selective Oral Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor, Is Well Tolerated and Active in Patients With Solid, Malignant Tumors: Results of a Phase I Trial

2002 • 764 citations

AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol

2003 • 615 citations

Aurora-A and an Interacting Activator, the LIM Protein Ajuba, Are Required for Mitotic Commitment in Human Cells

2003 • 610 citations

Human TPX2 is required for targeting Aurora-A kinase to the spindle

2002 • 563 citations

A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines

1997 • 483 citations

Suppression of BRAF(V599E) in human melanoma abrogates transformation.

2003 • 412 citations

Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs

1998 • 380 citations

A Small Interfering RNA Targeting Vascular Endothelial Growth Factor as Cancer Therapeutics

2004 • 377 citations

Aurora-A Kinase Maintains the Fidelity of Early and Late Mitotic Events in HeLa Cells

2003 • 361 citations

Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast.

1999 • 306 citations

Amplification/Overexpression of a Mitotic Kinase Gene in Human Bladder Cancer

2002 • 303 citations

Overexpression and Amplification of Aurora-A in Hepatocellular Carcinoma

2004 • 302 citations

Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer.

2003 • 300 citations

High-resolution characterization of the pancreatic adenocarcinoma genome

2004 • 279 citations

Focus on pancreas cancer

2002 • 215 citations

Aurora A, Meiosis and Mitosis

2004 • 153 citations

Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma

1997 • 125 citations

A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma

2001 • 92 citations

The mitotic serine threonine kinase, Aurora-2, is a potential target for drug development in human pancreatic cancer

2004 • 77 citations

Paclitaxel and concurrent radiation for locally advanced pancreatic cancer

2001 • 67 citations

The Human PMS2L Proteins Do Not Interact with hMLHl, a Major DNA Mismatch Repair Protein

1999 • 51 citations

Establishment of six human pancreatic cancer cell lines and their sensitivities to anti-tumor drugs.

1986 • 47 citations

Phase II Study of Docetaxel in Patients with Pancreatic Cancer Previously Untreated with Cytotoxic Chemotherapy

2002 • 41 citations

Molecular Pathology of Pancreatic Cancer

2004 • 40 citations

[Meiosis and mitosis].

1968 • 24 citations

Cited By (0)

No citing papers found in database

RNA Interference Targeting Aurora Kinase A Suppresses Tumor Growth and Enhances the… (2005) – Cancer Research | Metascience Observatory Explorer